Vera Therapeutics, Inc.VERANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-135.65M
↓ 123% below average
Average (5y)
$-60.76M
Historical baseline
Range
High:$-10.41M
Low:$-135.65M
CAGR
+67.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-135.65M | -47.1% |
| 2023 | $-92.24M | -36.3% |
| 2022 | $-67.66M | -185.4% |
| 2021 | $-23.71M | +32.1% |
| 2020 | $-34.91M | -235.2% |
| 2019 | $-10.41M | - |